Connect Biopharma Holdings Limited (CNTB) Social Stream



Connect Biopharma Holdings Limited (CNTB): $1.00

0.05 (-4.76%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add CNTB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#251 of 398

in industry

CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts

Use the tables below to see what analysts covering CONNECT BIOPHARMA HOLDINGS LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 3 $32 $27 $30 $1.05 2757.14%
2022-04-08 3 $25 $19 $22 $1.05 1995.24%
2022-05-04 3 $13 $1.5 $7.833 $1.05 646%
2022-06-06 4 $13 $1.5 $7.125 $1.05 578.57%
2022-09-15 4 $9 $1.75 $5.687 $1.05 441.62%
2023-02-08 4 $7 $1.75 $5.187 $1.05 394%
2023-04-12 3 $7 $1.75 $5.187 $1.05 394%
2023-07-11 2 $7 $5 $6.333 $1.05 503.14%
2023-09-12 1 $7 $7 $7 $1.05 566.67%
2023-09-13 2 $7 $5 $6 $1.05 471.43%

The Trend in the Analyst Price Target


CNTB's average price target has moved down $16 over the prior 17 months.

CNTB reports an average of 480.32% for its upside potential over the past 31 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 4 7 1.75 5.187 1.17 343.33%
2023-04-12 2 7 1.75 5.187 1.12 363.12%
2023-04-12 3 7 5.00 6.333 1.12 465.45%
2023-04-12 3 7 1.75 5.187 1.12 363.12%
2023-09-13 2 7 5.00 6.000 0.78 669.23%

CNTB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


CNTB's average broker recommendation rating improved by 0.5 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTB as an investment opportunity.

  • In terms of how CONNECT BIOPHARMA HOLDINGS LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1032.5% of that group.
  • CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 79.55% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, CONNECT BIOPHARMA HOLDINGS LTD's average analyst price target is higher than 114.11% of them.
  • In the context of Healthcare stocks, CONNECT BIOPHARMA HOLDINGS LTD's variance in analysts' estimates is lower than -479.17% of them.

In the Pharmaceutical Products industry, LVTX, EWTX, and DSGN are the three stocks most similar to CONNECT BIOPHARMA HOLDINGS LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding CNTB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!